CULVER CITY, Calif., April 15, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has completed multiple submissions to the FDA including an sBLA for ...

CULVER CITY, Calif., April 21, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln ...

ImmunityBio, Inc. , a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in non-muscle invasive bladder cancer carcinoma in situ (NMIBC ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As of 17 April at 14:52:28 GMT-4. Market open.

At close: 17 April at 5:15:00 pm GMT-3 ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

As of April 9 at 10:48:33 a.m. EDT. Market Open.